IRIS
SANSONNO, Domenico Ettore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.821
EU - Europa 2.628
AS - Asia 1.516
SA - Sud America 356
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 14.338
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.802
CN - Cina 888
SE - Svezia 635
SG - Singapore 531
UA - Ucraina 505
DE - Germania 386
RU - Federazione Russa 373
BR - Brasile 335
FI - Finlandia 279
IT - Italia 185
GB - Regno Unito 131
IE - Irlanda 36
FR - Francia 32
IN - India 27
BE - Belgio 15
HK - Hong Kong 14
CA - Canada 11
TR - Turchia 11
NL - Olanda 8
RO - Romania 8
AR - Argentina 7
IR - Iran 7
PL - Polonia 7
IQ - Iraq 6
DK - Danimarca 5
MA - Marocco 5
VN - Vietnam 5
AT - Austria 4
UZ - Uzbekistan 4
VE - Venezuela 4
AL - Albania 3
CO - Colombia 3
EU - Europa 3
PK - Pakistan 3
AU - Australia 2
AZ - Azerbaigian 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
ID - Indonesia 2
KG - Kirghizistan 2
LT - Lituania 2
MX - Messico 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ES - Italia 1
GA - Gabon 1
GT - Guatemala 1
IM - Isola di Man 1
JO - Giordania 1
JP - Giappone 1
KE - Kenya 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MT - Malta 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PY - Paraguay 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UY - Uruguay 1
YE - Yemen 1
ZA - Sudafrica 1
Totale 14.338
Salva come PNG Salva come JPEG
Città #
Fairfield 1.235
Jacksonville 1.191
Chandler 1.071
Woodbridge 859
Ashburn 646
Houston 488
Seattle 481
Nyköping 461
Cambridge 430
Wilmington 421
Ann Arbor 322
Singapore 264
Nanjing 261
Lawrence 255
Roxbury 253
Des Moines 174
New York 127
Boardman 120
Beijing 109
Princeton 95
Inglewood 92
Shenyang 77
Nanchang 70
Hebei 64
Brooklyn 61
San Diego 56
Santa Clara 46
Tianjin 46
Grafing 44
Jiaxing 41
Changsha 37
Dublin 35
Bari 31
Dearborn 27
Helsinki 27
Los Angeles 27
Jinan 25
Pune 17
São Paulo 17
London 16
Ningbo 16
Norwalk 16
Brussels 15
Guangzhou 15
Paris 15
Hong Kong 13
San Francisco 13
Tappahannock 13
San Mateo 11
Washington 10
Hefei 9
Zhengzhou 9
Belo Horizonte 8
Bologna 8
Indiana 8
Redwood City 8
Rio de Janeiro 8
Shanghai 8
Auburn Hills 7
Guarulhos 7
Hangzhou 7
Rome 7
Toronto 7
Ardabil 6
Augusta 6
Brasília 6
Hounslow 6
Kilburn 6
Milan 6
Moscow 6
Napoli 6
Taizhou 6
Copenhagen 5
Leawood 5
Osasco 5
Baghdad 4
Curitiba 4
Dong Ket 4
Kunming 4
Lowicz 4
Monmouth Junction 4
Nuremberg 4
Petrópolis 4
Seelze 4
Tashkent 4
Triggiano 4
Wuxi 4
Betim 3
Cariacica 3
Cuiabá 3
Duque de Caxias 3
Goiânia 3
Islington 3
Itajaí 3
Itatiba 3
Joinville 3
João Pessoa 3
Lucca 3
Marília 3
Medellín 3
Totale 10.513
Salva come PNG Salva come JPEG
Nome #
Recent patents relating to HCV molecules like putative targets for therapeutic intervention. 124
null 122
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 117
The expanding spectrum of HCV-related cryoglobulinemic vasculitis: a narrative review 115
HCV RNA genomic sequences and HCV-E2 glycoprotein in sural nerve biopsies from hcv-infected patients with peripheral neuropathy 115
HCV-related cryoglobulinemic vasculitis: An overview 113
The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and overt B-cell malignancy 112
Validation of the classification criteria for cryoglobulinaemic vasculitis 111
Transarterial Chemoembolization Plus Sorafenib: A Sequential Therapeutic Scheme for HCV-Related Intermediate-Stage Hepatocellular Carcinoma: A Randomized Clinical Trial. 107
Role of the receptor for the globular domain of C1q protein in the pathogenesis of hepatitis C virus-related cryoglobulin vascular damage 106
Combined Effects of 2 Interleukin 28B Polymorphisms on the Therapeutic Outcome of Hepatitis C Patients With Circulating Cryoglobulins 106
B CELLS AND HCV: AN INFECTION MODEL OF AUTOIMMUNITY 105
B-cell depletion in the treatment of mixed cryoglobulinemia. 102
Antibodies to glutaraldehyde-polymerized human albumin (anti-pHSA) in viral hepatitis. 100
Anticorpi anti-GOR. Caratterizzazione di autoantigeni ed autoanticorpi. 100
A RAPID DIRECT MICROWAVE IRRADIATION TECHNIQUE FOR DEMONSTRATING HEPATITIS-C VIRUS-ASSOCIATED C100 PROTEIN IN FORMALIN-FIXED LIVER-TISSUE 98
Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: viral detection in gastric low-grade lymphoma associated with autoimmune disease and in chronic gastritis 97
Hepatitis A virus and non-A, non-B virus superinfections in HBsAg chronic carriers. 96
Activation-induced cytidine deaminase in B cells of hepatits C virus-related cryoglobulinaemic vasculitis 96
null 96
Hepatitis C virus infection, cryoglobulinaemia, and beyond 95
Detection and quantitation of HCV core protein in single hepatocytes by means of laser capture microdissection and enzyme-linked immunosorbent assay 95
B-Cell lymphomas associated with HCV infection 93
Impact of immunogenetic IL28B polymorphism on natural outcome of HCV infection 92
Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseases 92
Barrett's esophagus and esophageal cancer: An overview. 92
In situ simultaneous detection of hepatitis C virus RNA and hepatitis C virus-related antigens in hepatocellular carcinoma 91
Hepatitis C virus-associated B-cell non-Hodgkin's lymphoma: clinical and therapeutic challenges 91
ANTIBODIES TO HEPATITIS-C VIRUS IN NON-A, NON-B POST-TRANSFUSION AND CRYPTOGENETIC CHRONIC LIVER-DISEASE 90
HEPATITIS C VIRUS RNA AND CORE PROTEIN IN KIDNEY GLOMERULAR AND TUBULAR STRUCTURES ISOLATED WITH LASER CAPTURE MICRODISSECTION 90
FAILURE TO DETECT HEPATITIS C VIRUS (HCV) GENOME BY POLYMERASE CHAIN REACTION IN HUMAN ANTI-HCV-POSITIVE INTRAVENOUS IMMUNOGLOBULINS 89
INCREASED SERUM LEVELS OF THE CHEMOKINE CXCL13 AND UP-REGULATION OF ITS GENE EXPRESSION ARE DISTINCTIVE FEATURES OF HCV-RELATED CRYOGLOBULINEMIA AND CORRELATE WITH ACTIVE CUTANEOUS VASCULITIS 89
MONOCLONAL ANTIBODY TREATMENT OF MIXED CRYOGLOBULINEMIA RESISTANT TO INTERFERON ALPHA WITH AN ANTI-CD20 89
Hepatitis C virus infection and mixed cryoglobulinemia: a striking association 89
Role of B-cell attracting chemokine-1 in HCV-related cryoglobulinemic vasculitis 88
Thymic stromal lymphopoietin in hepatitis C virus-related cryoglobulinemic vasculitis: Gene expression level and protein distribution 88
An enzyme-linked immunosorbent assay for the detection of autoantibodies to albumin. 87
Hepatitis C virus infection, lymphoproliferation and non-Hodgkin’s B cell lymphoma 86
A METHOD FOR DETECTING SPECIFIC ANTI-C100 PROTEIN ANTIBODIES OF IGM ISOTYPE IN HEPATITIS-C VIRUS-INFECTION 86
Therapy for hepatitis C virus-related cryoglobulinemic vasculitis. 84
Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agents. 82
HCV-ASSOCIATED B CELL CLONALITIES IN THE LIVER DO NOT CARRY THE T(14; 18) CHROMOSOMAL TRANSLOCATION 82
PATIENTS WITH MIXED CRYOGLOBULINEMIA AND HCV INFECTION, IN PRESENCE OR ABSENCE OF AUTOIMMUNE THYROIDITIS, HAVE HIGH SERUM LEVELS OF (CXC MOTIF) LIGAND (CXCL)9 AND CXCL11 CHEMOKINES 80
Immune-related disorders and extrahepatic diseases in chronic HCV infection. 79
MIXED CRYOGLOBULINEMIA: A MODEL OF VIRUS-RELATED DISEASE IN INTERNAL MEDICINE 79
Intrahepatic B cell clonal expansions and extrahepatic manifestations of chronic HCV infection 79
Demonstration and distribution of HCV RNA sequences by in situ hybridization and HCV-related proteins by immunohistochemistry in the liver tissue of patients with chronic HCV infection 78
Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia 78
C4d: a valuable marker of activation of the classical complement pathway in mixed cryoglobulinemia 78
Ibridizzazione in situ non isotopica. Attualità e prospettive 78
null 78
Angiogenesis and anti-angiogenesis in hepatocellular carcinoma 78
Cytokines and HCV-Related Disorders. 78
Caratterizzazione di lesione metastatica da carcinoma della mammella con angioecografia. Caso clinico 77
HCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations 77
The higher prevalence of B-cell non-Hodgkin's lymphoma in HCV-positive patients with and without cryoglobulinemia 77
Molecular characterization of B-cell clonal expansions in the liver of chronically hepatitis C virus-infected patients 77
IGM ANTI-C100-3 ANTIBODIES IN HEPATITIS-C VIRUS-INFECTION 76
Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations 75
Role of the HLA class II - HCV-related disorders 75
Amyloidosis: clinical picture, immunological and biomolecular features, treatment prospects 74
H. pylori infection and gastric cancer: state of the art (review). 74
Multidisciplinary approach for HCC patients: hepatology for the oncologists 74
Correlation between hepatitis B virus deoxyribonucleic acid and receptors for polymerized human albumin in HBV chronic infection. 73
HCV inhibits antigen processing and presentation and induces oxidative stress response in gastric mucosa 73
IMMUNOCHEMICAL AND BIOMOLECULAR STUDIES OF CIRCULATING IMMUNE COMPLEXES ISOLATED FROM PATIENTS WITH ACUTE AND CHRONIC HEPATITIS C VIRUS INFECTION 73
Detection of receptors for polymerised human albumin by immunoperoxidase and immunoadherence in liver tissue of HBsAg chronic carriers. 72
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2 72
Current and emerging therapeutic approaches in HCV-related mixed cryoglobulinemia 71
Receptor activity for polymerised human albumin in hepatitis B vaccine. 71
Cryoglobulinemic Vasculitis 70
Endocrine manifestations of hepatitis C virus infection 69
Preliminary classification criteria for the cryoglobulinaemic vasculitis 69
Hepatitis C virus infection, mixed crioglobulinemia, and non-Hodgkin’s lymphoma: an emerging picture 69
B-cell frequency in HCV-related mixed cryoglobulinemia. 68
EXPRESSION AND DISTRIBUTION OF A HUMAN COLON-CARCINOMA-ASSOCIATED ANTIGEN IN NORMAL AND DISEASED LIVER-TISSUE 67
Impact of Cryoglobulinemic Syndrome on the Outcome of Chronic Hepatitis C Virus Infection: A 15-Year Prospective Study. 67
Antiviral therapy in HCV-positive non-Hodgkin's lymphoma: pathogenetic implications 67
DETECTION OF HEPATITIS C VIRUS (HCV) PROTEINS BY IMMUNOFLUORESCENCE AND HCV RNA GENOMIC SEQUENCES BY NON-ISOTOPIC IN SITU HYBRIDIZATION IN BONE MARROW AND PERIPHERAL BLOOD MONONUCLEAR CELLS OF CHRONICALLY HCV-INFECTED PATIENTS 65
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015 64
Antikörper gegen hepatitis-C-viren in humanen intravenösen immunoglobulinen. 63
Anti-C100 antibody of IgM isotype in hepatitis c virus-associated chronic liver disease 63
Potential neutralizing properties of anti-E2 antibodies in HCV-infected patients with lymphoproliferative disorders. 63
Hepatitis C virus infection involves CD34+ hematopoietic porgenitor cells in hepatitis C virus chronic carriers. 63
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients 63
PIRR therapy in HCV-related mixed cryoglobulinemia 62
Amyloidosis: clinical picture, immunological and biomolecular features, treatment prospects. 62
B-cell clonal expansion in liver tissue of HCV+ patients 62
GRANULOCYTOPENIA AFTER COMBINED THERAPY WITH INTERFERON AND ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS - EVIDENCE FOR A SYNERGISTIC HEMATOLOGIC TOXICITY 62
MIXED CRYOGLOBULINEMIA SYNDROME AS AN ADDITIONAL AUTOIMMUNE DISORDER ASSOCIATED WITH RISK FOR LYMPHOMA DEVELOPMENT 62
Espansione clonale dei linfociti B intraepatici ottenuti da portatori cronici del virus C dell'epatite (HCV) con e senza crioglobulinemia mista 61
null 61
The cryoglobulins: an overview 61
Type II mixed cryoglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses 61
Demonstration of HBsAg as the antigen component in circulating immune complexes detected by peg-solid phase test. 60
PEGYLATED INTERFERON-A, RIBAVIRIN AND RITUXIMAB COMBINED THERAPY OF HEPATITIS C VIRUS-RELATED MIXED CRYOGLOBULINEMIA: A LONG-TERM STUDY 60
HEPATITIS C VIRUS WITHIN A MALIGNANT LYMPHOMA LESION IN THE COURSE OF TYPE II MIXED CRYOGLOBULINEMIA 60
Mixed cryoglobulinemia as a model of systemic vasculitis 59
The emerging extrahepatic manifestations of hepatitis C virus infection in chronic hepatitis and mixed cryoglobulinemia 59
Serum binding activity for human albumin polymers in acute and chronic virus hepatitis. 59
Totale 8.123
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.768
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.768
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020385 0 0 0 0 0 0 0 0 0 0 308 77
2020/20212.136 252 171 233 67 265 82 191 90 277 285 133 90
2021/20221.545 43 226 7 86 58 117 58 99 76 74 300 401
2022/20232.708 417 190 139 307 291 424 16 310 489 10 60 55
2023/2024721 89 176 31 31 54 200 16 36 1 12 4 71
2024/20251.641 33 43 342 76 52 294 169 281 159 152 40 0
Totale 14.473